Pfizer boss flags likelihood that extra jabs will be required – raising prospect of increased global demand Covid booster shot could be needed after nine to 12 months, White House says Experts say suggestions that a third dose of Pfizer may be needed within 12… Read More »Covid booster shot warning ‘underlines urgent need for Australia to make mRNA vaccines’
This brief provides an overview of social determinants of health and a look at how adults are faring across an array of measures over a year into the pandemic.
This issue brief provides an overview of COVID-19 vaccine passports, including what they are, where they are being used, and potential implementation issues.
Around the country and in parts of the world, COVID-19 vaccination efforts continue to grow, leaving people wondering about vaccine requirements and ways to certify vaccine status. “Vaccine passports,” a paper or digital form certifying that a person has been vaccinated, have garnered increased interest… Read More »Vaccine Passports: What We Know and What to Consider
Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness, has died from COVID-19.
Analysis rebuts claim by Boris Johnson that jab was developed ‘because of greed’ Coronavirus – latest updates See all our coronavirus coverage At least 97% of the funding for the development of the Oxford/AstraZeneca Covid-19 vaccine has been identified as coming from taxpayers or charitable… Read More »Oxford/AstraZeneca Covid vaccine research ‘was 97% publicly funded’
A phase 3 trial of Romark’s antiviral drug NT-300 has missed the main objective in a phase 3 trial in mild to moderate COVID-19 patients, but could still have a shot at emergency use authorisation (EUA), according to the US company. The Florida-based firm has… Read More »Romark eyes FDA okay for COVID antiviral despite mixed trial results
New strains such as the South African variant that’s emerged in south London will require constant vigilance as lockdown eases All viruses mutate. They do this to adapt and survive better in their specific host. The virus that causes Covid-19 is no different: it has… Read More »Will Covid vaccines protect us against new variants? | Julian Tang
Analysis: buying new and existing technologies ensured alternatives if a vaccine failed or had supply issues Coronavirus – latest updates See all our coronavirus coverage The government has said the decision by Johnson & Johnson to delay the supply of its Covid vaccine to Europe,… Read More »UK strategy of backing several Covid vaccines seems to be paying off
Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has… Read More »EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay
US health authorities have recommended pausing dosing with Johnson & Johnson’s COVID-19 vaccine as they investigate cases of blood clots also observed in some people taking the AstraZeneca shot. The FDA said there had been reports of six cases of cerebral venous sinus thrombosis (CVST)… Read More »US seeks halt on J&J COVID vaccine rollout as clot concerns spread
The JCVI has confirmed the next phase of the COVID-19 vaccination programme will continue to be based on age, but recommended that local NHS teams target men, those who are obese, people from certain ethnic groups and those experiencing social deprivation to encourage take up.
Staff at a GP surgery in Surrey have been left completely demoralised after they were targeted by anti-vaccination material last week – the second attack in less than a month.
COVID-19 vaccination has been extended to patients aged 45-49 after the government announced it had met a mid-April target of offering jabs to all 32m patients UK-wide in the first nine priority cohorts.
Fear of third wave and new variants as sub-Saharan vaccine distribution is dogged by supply disruption Coronavirus – latest updates See all our coronavirus coverage Millions of healthcare workers in sub-Saharan Africa continue to risk their lives to fight Covid-19 as authorities across the continent… Read More »African health workers left without Covid jabs as paltry supplies dwindle
Woman in her 40s in Western Australia reported to be in hospital in a stable condition after developing clot Health authorities have concluded a second case of a rare blood clot syndrome in Australia “is likely” linked to the AstraZeneca vaccine. The case occurred in… Read More »Australia reports second blood clot case ‘likely’ linked to AstraZeneca Covid vaccine
Private insurance companies expect to pay $2.1 billion in rebates to consumers in 2021 due to excessive premiums in recent years.
A common corticosteroid shortens COVID-19 recovery times for patients aged over 50 who are at high risk of developing severe illness, a groundbreaking GP-led trial has found.
A common corticosteroid shortens COVID-19 recovery times for patients aged over 50 who are at high risk of developing severe illness, a groundbreaking GP-led trial has found.
The COVID-19 pandemic has left no person unaffected, but Black Americans have been disproportionately impacted. Black adults are nearly four times more likely to be hospitalized from the virus and nearly three times more likely to die from the virus than their white counterparts. At… Read More »Diversifying clinical trials and fighting disease requires equity and trust
Hope that AstraZeneca’s diabetes and heart failure drug Farxiga might treat patients hospitalised with COVID-19 have been dashed after the drug failed to make an impact in a phase 3 trial. The DARE-19 trial showed that giving Farxiga (dapagliflozin) to COVID-19 patients at risk of… Read More »AstraZeneca’s Farxiga fails phase 3 COVID-19 test
Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grown Coronavirus – latest updates See all our coronavirus coverage Vaccine-makers around the world face shortages of vital components including large plastic growbags, according to the head of… Read More »Global Covid vaccine rollout threatened by shortage of vital components
This brief presents available data on COVID-19 vaccinations among AIAN people from federal and state sources and discusses factors contributing to success in these vaccination efforts.
Supplies of COVID-19 vaccine for first-dose vaccinations at GP-led vaccination sites will halt completely for a fortnight from 12 April, NHS England’s primary care medical director has said.
Supplies of COVID-19 vaccine for first-dose vaccinations at GP-led vaccination sites will halt completely for a fortnight from 12 April, NHS England’s primary care medical director has said.
EMA says four serious cases reported, one fatal, and also expands inquiry into AstraZeneca vaccine Coronavirus – latest updates See all our coronavirus coverage The EU’s drug regulator is reviewing reports of rare blood clots in four people who received Johnson & Johnson’s Covid-19 vaccine… Read More »EU agency examines reports of blood clots with J&J Covid vaccine
Readers respond to the latest recommendations about the AstraZeneca Covid vaccine Your editorial calling for clarity on the AstraZeneca vaccine’s side-effects risks both being unclear and undermining confidence (The Guardian view on the AstraZeneca vaccine: confidence from clarity, 7 April). You imply that the rate… Read More »Clarity and openness are key to vaccine confidence | Letters
This report examines in depth the vaccine-related views and experiences of rural residents and shows more than half of rural adults say they have already gotten at least one dose of a COVID-19 vaccine or will do so as soon as possible. Rural residents report… Read More »KFF COVID-19 Vaccine Monitor- Rural America
Eli Lilly’s JAK inhibitor Olumiant has missed its main objective in a phase 3 trial in hospitalised COVID-19 patients, but had a significant effect on mortality, a secondary endpoint. The perplexing data showed that patients treated with Olumiant (baricitinib) were 2.7% less likely to progress… Read More »Lilly’s Olumiant flunks COVID-19 trial – or does it?
Experts say the development of blood clots after getting the jab is still an ‘exceedingly rare’ side effect. So what triggered the government’s change in position? Australia’s vaccine rollout is facing a major shake-up after the federal government heeded the advice of its independent health… Read More »What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?
More than seven in 10 COVID-19 jabs administered UK-wide since the start of April have been second doses as reduced supply saw total vaccinations per week drop to the lowest point since mid-January.
More than seven in 10 COVID-19 jabs administered UK-wide since the start of April have been second doses as reduced supply saw total vaccinations per week drop to the lowest point since mid-January.
Prof David Spiegelhalter says advantages of vaccinating young people far outweigh risks Coronavirus – latest updates See all our coronavirus coverage People in their 20s should continue to get vaccinated against Covid despite the very rare cases of blood clotting linked to the Oxford/AstraZeneca vaccine… Read More »Coronavirus: UK expert urges people in 20s to keep getting vaccine
Downing Street will not confirm or deny report that more than 700,000 Covid jabs were sent after EU blocked export Coronavirus – latest updates See all our coronavirus coverage British ministers and officials did not deny that more than 700,000 shots of the AstraZeneca vaccine… Read More »UK ministers silent on AstraZeneca vaccine shipment to Australia
A new issue brief reviews excess death rates in the U.S. and peer countries by age groups to examine how the pandemic has affected excess mortality rate among younger people. The analysis looks specifically at the excess deaths that arose in 2020 to examine how… Read More »COVID-19 Pandemic-Related Excess Mortality and Potential Years of Life Lost in the U.S. and Peer Countries
A new KFF issue brief examines 2020 data on excess mortality – the number of deaths above what is expected in a typical year – and finds that among similarly large and wealthy nations, the United States had the highest premature excess mortality rate in… Read More »Compared to Peer Countries, the U.S. Had the Highest Rate of Mortality Among People Under Age 65 and Potential Years of Life Lost in 2020 due to the Pandemic
GP-led vaccination sites should offer under-30s due to receive a first dose of AstraZeneca COVID-19 vaccine from 9 April a chance to rebook at a site offering alternative vaccines, NHS England has said.
GP-led vaccination sites should offer under-30s due to receive a first dose of AstraZeneca COVID-19 vaccine from 9 April a chance to rebook at a site offering alternative vaccines, NHS England has said.
GP-led vaccination sites should offer under-30s due to receive a first dose of AstraZeneca COVID-19 vaccine from 9 April a chance to rebook at a site offering alternative vaccines, NHS England has said.
A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’. An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive –… Read More »Digital tool will be tested against COVID-19 ‘brain fog’
The UK drugs regulator has said people aged under 30 should be offered an alternative to the AstraZeneca COVID-19 vaccine, because of evidence linking it to rare blood clots. Updated figures from the Medicines and Healthcare products Regulatory Agency (MHRA) reveal 79 people experienced blood… Read More »UK will offer under-30s alternative to AZ’s COVID jab
There’s a recent rise in national optimism that says—maybe—we have turned the corner on the pandemic lockdown. Admittedly, it’s been a tough year for nearly everyone, but miraculous vaccines and declining death rates have stirred newfound optimism. COVID-19 PUBLIC EDUCATION CAMPAIGN by the U.S. Department… Read More »How Doctors and Hospitals Can Help Defeat COVID-19 Vaccine Resistance and Misinformation
Iain Duncan Smith, former leader, and another MP, warn of eroded confidence in vaccine plan after ‘messy’ MHRA advice Coronavirus – latest updates See all our coronavirus coverage A decision to offer people under 30 an alternative vaccine to the AstraZeneca jab has prompted concern… Read More »AstraZeneca jab worry may play into hands of anti-vaxxers, say Tories
Vaccitech, the Oxford-based firm behind the AstraZeneca vaccine, is a high-profile float that slipped away A glowing, Deliveroo-style tribute from Rishi Sunak will not be required for this flotation. Vaccitech, the Oxford-based firm that owns some of the key biotechnology behind the AstraZeneca Covid vaccine,… Read More »A prized UK biotech firm looks to Wall Street, much to Rishi Sunak’s dismay
England’s deputy chief medical officer says delay would be precaution against rare side-effect of blood clots Coronavirus – latest UK updates See all our coronavirus coverage People under 30 have been told there may be a “small delay” to when they will receive a coronavirus… Read More »Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam
People under 30 will be offered alternatives to the Oxford/AstraZeneca COVID-19 vaccine as a first choice after a ‘course correction’ by UK health authorities amid concern over a link to rare blood clots.
People under 30 will be offered alternatives to the Oxford/AstraZeneca COVID-19 vaccine as a first choice after a ‘course correction’ by UK health authorities amid concern over a link to rare blood clots.
People under 30 will be offered alternatives to the Oxford/AstraZeneca COVID-19 vaccine as a first choice after a ‘course correction’ by UK health authorities amid concern over a link to rare blood clots.
As the vaccine rollout continues across the country, a key question is whether and how far governments and employers can go to require the public and workers to get vaccinated. Our new issue brief explains the legal basis for vaccine mandates and what limitations might… Read More »Understanding COVID-19 Vaccine Mandates
People urged to keep getting Covid vaccine, with EMA and MHRA expected to give updates on investigation into rare blood clots Coronavirus – latest updates See all our coronavirus coverage Government advisers say concerns over the Oxford/AstraZeneca jab are being taken “very seriously” and “very… Read More »AstraZeneca jab: UK government says concerns being investigated thoroughly
Oxford University has suspended a clinical trial of its AstraZeneca-partnered COVID-19 vaccine in children and adolescents while a possible link to rare cases of blood clotting is investigated by the UK drugs regulator. Around 300 volunteers have been enrolled into the trial, but investigators have… Read More »Paediatric trial of AZ COVID jab ‘halted as a precaution’
Despite scientific advice to continue getting the jab, answers about fatal blood clots are urgently needed Coronavirus – latest updates See all our coronavirus coverage Vaccines have side-effects, as do all medicines. Most often, jabs cause sore arms, a headache or a bit of nausea… Read More »AstraZeneca Covid vaccine: weighing up the risks and rewards
Anglo-Swedish company ‘solely’ to blame, says EU commissioner as bloc misses April vaccination target AstraZeneca has been squarely blamed by the EU for its comparatively slow Covid vaccine rollout after the bloc of 27 states failed to achieve its target to vaccinate 80% of older… Read More »EU blames AstraZeneca ‘failure’ for sluggish Covid vaccine rollout
People in the UK will start receiving doses of Moderna’s COVID-19 vaccine in around two weeks’ time, according to vaccines minister Nadhim Zahawi. The roll-out of the third coronavirus shot will come as the UK exits its second lockdown round, and in time to offset… Read More »Could Moderna shot save UK’s under-50s COVID vaccination push?
AstraZeneca is shifting production of its COVID-19 vaccine away from a plant in Baltimore which also makes Johnson & Johnson’s shot, after human error resulted in the contamination of 15 million doses. The mix-up at the facility operated by contract manufacturer Emergent BioSolutions resulted in… Read More »AZ exits US vaccine plant after mix-up spoils J&J’s COVID jab
Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clots Coronavirus – latest updates See all our coronavirus coverage The UK’s medicines regulatory body has said that no decision has been made on any regulatory action relating to the Oxford/AstraZeneca… Read More »Medicines watchdog says no decision made AstraZeneca jab for under-30s
The News Leaders Association (NLA) awarded KFF’s Kaiser Health News (KHN) and Guardian US the 2021 Batten Medal for Coverage of the Coronavirus Pandemic for their year-long “Lost on the Frontline” investigation documenting the lives of more than 3,600 health care workers in the U.S.… Read More »KHN and Guardian US Win Batten Medal for “Lost on the Frontline”
An ongoing problem in clinical trials over the years has been a failure to procure diverse enough representation among the participants. For a long time, this was due to bias and oversight on the part of the research community, and the consequence was a lack… Read More »COVID-19 Treatment Trial Reaches Out to Communities of Color
Experts urge public to go for inoculations as benefits far outweigh potential complications Coronavirus – latest updates See all our coronavirus coverage Health officials are becoming increasingly worried that younger people will reject Covid jabs as concerns about the AstraZeneca vaccine continue to grow. A… Read More »Blood clot cases ‘could dent faith of young women in AstraZeneca’
Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our coronavirus coverage Two very different jabs have been responsible for inoculating Britain’s strikingly high number of vaccine recipients – with… Read More »Two new vaccines on the way – with more to follow this year
This is what happens when a third of humanity depends on one manufacturer for Covid jabs. We need to waive patents now As the UK’s vaccination programme was “knocked off course” due to a delay in receiving five million doses of the AstraZeneca vaccine from… Read More »The world’s poorest countries are at India’s mercy for vaccines. It’s unsustainable | Achal Prabhala and Leena Menghaney
Findings based on two doses three weeks apart are first to show shot remains effective for many months Coronavirus – latest updates See all our coronavirus coverage The coronavirus vaccine developed by Pfizer and its German partner BioNTech protects against symptomatic Covid for up to… Read More »Pfizer vaccine has 91% efficacy for up to six months, trial shows
The head of the EMA has reiterated that there is no evidence to limit the use of AstraZeneca’s COVID-19 vaccine in any age group, after Germany and Canada imposed restrictions in younger patients. “Our position has not changed” from a safety update two weeks ago,… Read More »EMA backs safety of AZ COVID-19 jab in all age groups
Drug firm in partnership with BioNTech to seek US approval after trials found vaccine ‘well-tolerated’ in school-age children Pfizer plans to seek emergency approval for its Covid vaccine in younger people after a US trial found the jab prevented the disease and was “well-tolerated” in… Read More »Pfizer finds Covid vaccine safe and effective for children 12 to 15
More than 26m people in England have now received at least one dose of COVID-19 vaccine – but with supplies set to ‘dry up’ over the coming month, how does progress vary between CCG areas?
More than 26m people in England have now received at least one dose of COVID-19 vaccine – but with supplies set to ‘dry up’ over the coming month, how does progress vary between CCG areas?
More than 26m people in England have now received at least one dose of COVID-19 vaccine – but with supplies set to ‘dry up’ over the coming month, how does progress vary between CCG areas?
More than 26m people in England have now received at least one dose of COVID-19 vaccine – but with supplies set to ‘dry up’ over the coming month, how does progress vary between CCG areas?
Among Those Who Have Not Been Vaccinated, 3 in 10 Are Unsure if They are Eligible Yet; Hispanic Adults and People with Low Incomes More Likely to Be Unsure The latest KFF COVID-19 Vaccine Monitor report finds enthusiasm for getting a COVID-19 vaccine continuing to… Read More »Vaccine Monitor: 6 in 10 Adults Have Either Gotten a COVID-19 Vaccine or Want To “as Soon as Possible;” “Wait and See” Group Continues To Shrink
Two antibodies targeting different parts of the COVID-19 virus spike protein, from Eli Lilly and GlaxoSmithKline/Vir Biotech, can cut viral load dramatically within a week. The BLAZE-4 trial found that co-administration of Lilly’s bamlanivimab – already granted emergency approval as a COVID-19 treatment – and… Read More »Lilly and GSK/Vir antibody pairing offers resistant COVID-19 hope
This Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. It explores vaccine intentions, information gaps, vaccine brand preferences, and tests a variety of… Read More »KFF COVID-19 Vaccine Monitor: March 2021
Immunisation panel says there is ‘substantial uncertainty about the benefit’ of the vaccine given risk of rare type of blood clot See all our coronavirus coverage Canada on Monday suspended the use of the Oxford/AstraZeneca coronavirus vaccine for people under 55 following concerns it might… Read More »Canada suspends use of AstraZeneca Covid vaccine for those under 55
Deal is intended to boost domestic supply amid fears potential export bans could hit vaccine shipments Coronavirus – latest updates See all our coronavirus coverage The UK will produce up to 60m doses of a Covid-19 vaccine under a new deal struck to boost domestic… Read More »UK to make up to 60m doses of Novavax Covid vaccine under GSK deal
GPs should work with partners to determine whether drive-through COVID-19 vaccination clinics could help to improve uptake in ‘low coverage areas’, according to updated guidance from NHS England.
GPs should work with partners to determine whether drive-through COVID-19 vaccination clinics could help to improve uptake in ‘low coverage areas’, according to updated guidance from NHS England.
GPs should work with partners to determine whether drive-through COVID-19 vaccination clinics could help to improve uptake in ‘low coverage areas’, according to updated guidance from NHS England.
GPs should work with partners to determine whether drive-through COVID-19 vaccination clinics could help to improve uptake in ‘low coverage areas’, according to updated guidance from NHS England.
The EU looks set to approve emergency use of a third antibody therapy for COVID-19 after its human medicines committee backed use of Celltrion’s regdanvimab at its March meeting. Regdanvimab (CT-P59) – which is currently under a rolling review at the EMA – can be… Read More »CHMP backs Celltrion’s regdanvimab antibody for COVID-19
The company has struggled, like its rivals, to keep up with demand. But it has achieved great things at low prices AstraZeneca is one of the shining stars of the pandemic. Not only did it produce a vaccine where other big players failed, the UK-Swedish… Read More »Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn
Newly accused of data manipulation by the US, AstraZeneca has faced unprecedented scrutiny over the past six months Coronavirus – latest updates See all our coronavirus coverage It was billed as the vaccine to deliver the world from Covid. But over the last six months,… Read More »How the AstraZeneca vaccine became a political football – and a PR disaster
‘This job makes me feel like I’m part of history.’
This brief use data from the American Community Survey (ACS) to provide estimates of eligibility for and the amount of financial assistance to purchase Marketplace coverage under the ARPA among both current individual market purchasers, as well as Marketplace-eligible uninsured people.
Boehringer Ingelheim invested €3.7 billion on R&D last year, the highest spend in its history, as it mobilised its scientists to seek out new therapies for COVID-19. Not all those efforts have been successful. Boehringer abandoned BI 764198, an inhibitor of TRPC6 in phase 2… Read More »COVID-19 drives Boehringer’s R&D spend to record level in 2020
Drugmaker isn’t entirely blameless but making it a political football for EU’s failures is simply ugly The European Union ought to be delighted. The “discovery” of a “stockpile” of 29m vaccine doses in Italy is really a non-discovery. The consignment is held at an authorised… Read More »Why a fresh AstraZeneca fightback is required in Covid vaccine info row | Nils Pratley
Batches were found when Italian police searched factory at request of European commission Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has dismissed as “inaccurate” a report in the Italian press that 29m doses of its Covid-19 vaccine found in factory near Rome… Read More »AstraZeneca dismisses claim 29m vaccine doses in Italy were bound for UK
This brief explores issues related to risks related to COVID-19, vaccine priority in state plans, and other policy options that affect access to vaccines for people experiencing homelessness.
Boris Johnson’s sense of humour seems to have got him into trouble again, at the most delicate of times. The Prime Minister reportedly told Conservative backbench MPs on a Zoom call that “capitalism” and “greed” was behind the success of the UK’s COVID-19 vaccination programme,… Read More »Boris Johnson slammed for saying “greed” is behind UK vaccine success
Worldwide focus on Covid-19 means a ‘minor issue’ is getting media attention, experts say Australia’s Covid vaccine rollout would be ‘dire’ without local AstraZeneca production, health chief says Australia’s drug regulator, the Therapeutic Goods Administration, has dismissed questions raised about “outdated information” in AstraZeneca vaccine… Read More »AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data
Bloc expected to assess countries’ Covid vaccination coverage and record in facilitating exports to EU Coronavirus – latest updates See all our coronavirus coverage The EU is expected to take into account the level of vaccination coverage in a country and its record in facilitating… Read More »EU to widen criteria for possible Covid vaccine export bans
Drug firm may have provided incomplete view of efficacy data from US trial, says safety monitor Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine against Covid has been dealt another blow within hours of AstraZeneca posting excellent results from its long-awaited… Read More »US agency questions AstraZeneca’s Covid vaccine trial data
GPs have been urged to offer COVID-19 jabs again to patients who have previously refused, after a study suggested vaccine hesitancy has declined sharply since December.
GPs have been urged to offer COVID-19 jabs again to patients who have previously refused, after a study suggested vaccine hesitancy has declined sharply since December.
Vaccinating the world is the only way out of Covid, but a mixture of nationalism and protectionism is blocking the exit Covid-19 has proved to be the greatest humanitarian and economic disaster of the century. A reported 2.7 million people have already died from the… Read More »The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial
PM stresses need to work with EU and says surge in infections is likely to ‘wash up on our shores’ Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has urged international cooperation over vaccines, saying a third wave of coronavirus elsewhere in… Read More »Boris Johnson: vaccine cooperation vital to help combat third Covid wave
Vaccination sites across the UK delivered almost 1.6m COVID-19 jabs in two days on 19 and 20 March to cap a record-breaking week for the vaccination programme.
GP practices will be supported with an extra £120m over the next six months through an expansion of the COVID-19 support fund unveiled by NHS England.
Reflecting on lessons learned from the pandemic, healthcare leaders pointed to the lack of coordination and glaring health disparities that hampered the U.S. pandemic response. Going forward, they hope to see future change in the healthcare system.
After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast track out of lockdown? Coronavirus – latest updates See all our coronavirus coverage For Stacey Harris, the hardest part of… Read More »Vaccine wars: the week that rocked the UK’s Covid jab rollout
Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved… Read More »France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously
Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved… Read More »France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously
Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live… Read More »The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe
Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live… Read More »The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe
The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped.… Read More »Patrick Vallance: the adviser who spoke scientific truth to power
The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped.… Read More »Patrick Vallance: the adviser who spoke scientific truth to power
The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of… Read More »How are Covid vaccines produced and why have there been delays?
The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of… Read More »How are Covid vaccines produced and why have there been delays?
EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines… Read More »European countries to resume AstraZeneca jabs after safety backing
EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines… Read More »European countries to resume AstraZeneca jabs after safety backing
The Oxford/AstraZeneca coronavirus vaccine is ‘safe and effective’ and its benefits outweigh the risks, Europe’s medicines regulator has said. The director of the European Medicines Agency, Emer Cooke, said the agency’s safety committee had reached ‘a clear scientific conclusion’ and had not found that the vaccine… Read More »AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video
The Oxford/AstraZeneca coronavirus vaccine is ‘safe and effective’ and its benefits outweigh the risks, Europe’s medicines regulator has said. The director of the European Medicines Agency, Emer Cooke, said the agency’s safety committee had reached ‘a clear scientific conclusion’ and had not found that the vaccine… Read More »AstraZeneca vaccine ‘safe and effective’, says European Medicines Agency – video
The Oxford/AstraZeneca COVID-19 vaccine is not linked to an increased risk of blood clots, EU and UK regulators have concluded after evidence reviews.
Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine… Read More »EU to send formal letter to AstraZeneca in Covid vaccine dispute
Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine… Read More »EU to send formal letter to AstraZeneca in Covid vaccine dispute
Around 12m second-dose COVID-19 jabs due next month will be delivered on time and some first doses will continue despite a major drop in expected supply, Matt Hancock has told MPs.
COVID-19 vaccination sites have been ordered to scale back plans for jabs beyond 29 March – after NHS officials confirmed a four-week slump in vaccine supply will ‘significantly constrain’ rollout.
The UK looks set to beat its target of offering a first COVID-19 jab to all patients in JCVI cohorts 1-9 by mid-April – as the NHS marked 100 days since the campaign began by opening invitations to all over-50s.
BMA and RCGP leaders have backed the Oxford/AstraZeneca COVID-19 vaccine as investigations continue into reports of blood clots.
Roche has launched a new test that will help monitor emerging variants of the SARS-CoV-2 coronavirus. In a statement the company said the cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission. Detecting… Read More »Roche launches test to monitor emerging coronavirus variants
Roche has launched a new test that will help monitor emerging variants of the SARS-CoV-2 coronavirus. In a statement the company said the cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission. Detecting… Read More »Roche launches test to monitor emerging coronavirus variants
The decision by around a dozen EU countries to suspend dosing with AstraZeneca’s COVID-19 vaccine is facing criticism, amid fears that it could undermine the response to the pandemic in Europe. Germany, France, Italy and Spain are among the member states that have announced a… Read More »States halting AZ jab a ‘disaster’ for EU’s COVID vaccination programme
European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend use Coronavirus – latest updates See all our coronavirus coverage Europe’s medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot’s benefits outweigh the risks… Read More »Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA
This data note estimates how tax credits premiums will change for people at various ages and incomes under the temporary boost in subsidies included in the American Rescue Plan Act of 2021, the COVID-19 relief plan signed into law in March 2021.
Most GP practices are likely to deliver COVID-19 vaccination to patients under 50 – and CCGs must not over-complicate the opt-in process, the BMA’s GP committee chair has said.
As the COVID-19 vaccine roll-out gains in intensity, it has become common to hear people toss out the names of pharmaceutical companies like Pfizer, Moderna and AstraZeneca with the same ease that they refer to their favorite brands of ketchup or peanut butter. This isn’t… Read More »Harris Poll Finds Large Boost in Pharma Industry Reputation
Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received… Read More »Ireland suspends AstraZeneca Covid vaccine over blood clot concerns
As of February 2021, there are three COVID-19 vaccines approved for emergency use in the U.S. and states are playing a central role in their timely distribution and prioritizing eligible populations. Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of… Read More »A Look at How Medicaid Agencies Are Assisting with the COVID-19 Vaccine Roll-Out
One in seven Londoners aged over 65 are yet to have a first dose of COVID-19 vaccine – more than three times the proportion unvaccinated in the rest of England.
GP practices in England have one week to choose whether to remain part of the COVID-19 vaccination programme beyond the first nine priority cohorts – as NHS England confirmed an acceleration in vaccine supply had been brought forward.
The EU’s medicines regulator has recommended granting conditional approval to a fourth COVID-19 vaccine – a single-dose shot from Johnson & Johnson’s Janssen unit – after a review by its human medicines committee. The CHMP has concluded that the Ad26.COV2.S vaccine can be used in… Read More »J&J’s COVID-19 shot backed for emergency use in EU
Jab has 97% efficacy against disease and death and 94% against infection without symptoms The Pfizer/BioNTech vaccine appears to give high protection against asymptomatic Covid-19, according to data from Israel – a finding that will boost hopes that mass vaccination can stop the spread of… Read More »Israeli real-world data on Pfizer vaccine shows high Covid protection
The latest report from the KFF COVID-19 Vaccine Monitor examines how the COVID-19 pandemic has impacted the lives of lesbian, gay, bisexual and transgender (LGBT) people and finds that larger shares of LGBT adults report economic losses and mental health struggles than their non-LGBT counterparts.… Read More »KFF COVID-19 Vaccine Monitor: The Impact of the COVID-19 Pandemic on LGBT People
This analysis examines the reported experiences among self-identified LGBT individuals based two months of KFF COVID-19 Vaccine Monitor reports and finds that LGBT people have experienced the COVID-19 pandemic differently than non-LGBT people, including being harder hit in some areas.
Health agency suspends use of Covid jab but says no conclusive link has been established Coronavirus – latest updates See all our coronavirus coverage Denmark’s national health agency has said it is temporarily suspending inoculations with the AstraZeneca vaccine after blood clots formed in several… Read More »Denmark pauses use of AstraZeneca vaccine to investigate blood clot reports
KFF has updated its 2021 Health Insurance Marketplace Calculator to reflect the expanded premium tax credits available to people who purchase their own coverage through their state’s health insurance exchange as passed by Congress in the American Rescue Plan Act and expected to be signed… Read More »Updated KFF Calculator Estimates Marketplace Premiums to Reflect Expanded Tax Credits in COVID-19 Relief Legislation
Almost 30% of GPs say they or clinical colleagues have been off work in the past month with mental health problems caused by working in the COVID-19 pandemic, a BMA poll reveals.
This brief reviews information available through state websites and publicly available vaccine distribution plans to provide greater insight into how states are addressing equity through vaccine allocation and distribution strategies, outreach and communications efforts, and data collection and reporting. It provides a snapshot and examples… Read More »How are States Addressing Racial Equity in COVID-19 Vaccine Efforts?
The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering… Read More »At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot
A laboratory study suggests Pfizer and BioNTech’s COVID-19 vaccine Comirnaty could be effective against a Brazilian variant of the SARS-CoV-2 virus – known as P.1 – that is worrying health officials around the world. The study suggests that serum taken from patients injected with the… Read More »Pfizer/BioNTech COVID jab works against Brazil variant; lab study
Many Relied on Another Person’s Help to Try to Get a Vaccine Appointment As many states and local authorities ramp up their COVID-19 vaccination efforts, the latest KFF COVID-19 Vaccine Monitor report provides the first in-depth look at Americans’ experiences trying to gather relevant information… Read More »KFF COVID-19 Vaccine Monitor Probes Americans’ Experiences Trying to Sign Up for a Vaccine and to Find Relevant Information
This report shows about half over the age of 65 say they have already received at least one dose of the vaccine or have scheduled an appointment to do so. It also examines how easy or difficult it has been for people to get an… Read More »KFF COVID-19 Vaccine Monitor: Experiences With Vaccine Access And Information Needs
A smartphone app that uses artificial intelligence to assess the sound of coughing has been launched in the UK, and according to its developer could be an early warning system for COVID-19 and other diseases of the lung. Hyfe uses acoustic technology to track users’… Read More »COVID cough app Hyfe launches in UK and Ireland
Building on deep scientific knowledge gained from decades of experience with viruses such as MERS, SARS, influenza, HIV and Hepatitis C, biopharmaceutical companies have made unprecedented progress in advancing treatments and vaccines to help fight COVID-19. At this time, three vaccines and several treatments have… Read More »ICYMI: WSJ showcases breakthrough science of COVID-19 vaccines and implications for future medicines
One in six doctors say local vaccination sites have been forced to rearrange sessions due to failed deliveries of COVID-19 jabs, according to a BMA survey.
The EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 who are at risk of developing severe disease, clearing the way for use in EU member states. The CHMP says bamlanivimab (LY-CoV555) can be given alone or administered… Read More »EMA backs emergency use of Lilly’s COVID antibodies
The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus coverage The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market… Read More »From Pfizer to Moderna: who’s making billions from Covid vaccines?
Earlier today, 31 PhRMA board members signed a letter to President Joe Biden applauding the Administration’s accelerating COVID-19 vaccine rollout, but also warning against efforts to undermine American intellectual property and innovation-dependent manufacturing jobs.
Italian government said the 250,000 doses of AstraZeneca vaccine must be kept in EU Coronavirus – latest updates See all our coronavirus coverage Australia has asked for a review of Italy’s decision to block the export of 250,000 doses of the AstraZeneca vaccine to its… Read More »Australia requests review of Italy’s block of vaccine export
More than 1m people UK-wide have now had two doses of COVID-19 vaccine, official figures will confirm today.
With EU countries breaking ranks in order to get access to the Russian Sputnik V COVID-19 vaccine, the EMA has started a rolling review of the shot. “EMA will assess Sputnik V’s compliance with the usual EU standards for effectiveness, safety and quality. While EMA… Read More »EMA starts rolling review of Sputnik V COVID vaccine
Row continues between EU and drug firm after shortfall in vaccine deliveries to bloc Coronavirus – latest updates See all our coronavirus coverage Italy has blocked the export of 250,000 doses of the Oxford/AstraZeneca vaccine to Australia in an escalation of a row with the… Read More »Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia
Across the industry, biopharmaceutical companies are working around the clock to meet the demands of COVID-19 vaccine manufacturing. Companies are working to source needed raw materials and other supplies and increasing manufacturing capacity to get COVID-19 vaccine shots in as many arms as possible. Even… Read More »How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing
Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group. The country’s drugs regulator previously limited use of the vaccine to the under-65s only, claiming that the data in the… Read More »Germany backtracks on AZ COVID vaccine age restriction
Majorities Favor Provisions to Expand Marketplace Tax Credits and Encourage States to Expand Medicaid As Congress considers an additional $1.9 trillion COVID-19 relief plan, more than a third (37%) of Americans say that someone in their household has had trouble paying basic living expenses over… Read More »KFF Tracking Poll: More Than a Third of Americans Say They’ve Struggled to Pay Living Expenses Since December; 6 in 10 Families Hit by COVID Have Lost A Job or Income
This poll examines the public’s assessments of the Biden administration’s handling of the coronavirus pandemic, the impact COVID-19 has had on people’s finances, and support for provisions of the latest COVID-19 relief bill. It examines the public’s views of the ACA and possible next steps.
Health secretary Matt Hancock has thanked GPs for their ‘monumental effort’ in delivering millions of COVID-19 jabs – and said the profession had been instrumental in helping the NHS ‘stand firm’ through the pandemic.
Deliveries of COVID-19 vaccine are set to double from 15 March compared with supplies available this week, NHS England has confirmed.
Another trial of convalescent plasma in people with COVID-19 has missed the mark, this time in mild to moderate disease, further dashing hopes that the therapy could have an impact on the infection. Convalescent plasma taken from recovered COVID-19 patients is laden with antibodies against… Read More »NIH abandons convalescent plasma trial in mild COVID
NHS England has promised to deliver thousands of pounds in missing payments to GP practices this month – after the BMA warned teams delivering COVID-19 jabs ‘cannot be expected to run on goodwill’.
The COVID-19 pandemic brought life-changing disruptions to people around the world and has turned the typical vaccine R&D process on its head. A combination of urgent need, unprecedented investments, and advances in genetic engineering has allowed what was once mere speculation to become not only… Read More »Genetic Vaccine Development for Infectious Diseases Summit
Both countries urged to take action to avoid pile-up of unused AstraZeneca vaccine doses Coronavirus – latest updates See all our coronavirus coverage Authorities in Germany and France are under pressure to come up with creative solutions to shift the AstraZeneca vaccine at higher speed… Read More »Covid: Germany and France under pressure to shift Oxford vaccine
Roche Diagnostics has launched a 15-minute nasal antigen test for COVID-19 in the UK, and says it has millions of the kits available straight away to help the country recover from the pandemic. The speedy test can turn around results within 15 minutes, without… Read More »Roche introduces 15-minute nasal COVID test in UK
If we continue to apply the technology without widespread agreement to these basic premises, we could dissolve people’s trust before we even earn it.
The FDA has approved emergency use of a third COVID-19 vaccine from Johnson & Johnson’s Janssen Biotech unit, the day after an advisory committee concluded it was safe and effective. Janssen’s Ad26.COV2.S vaccine has been authorised for use in people aged 18 or over after… Read More »FDA clears third emergency COVID-19 vaccine from J&J
Healthcare workers with obesity found to produce only about half the antibodies healthy people do Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine may be less effective in people with obesity, data suggests. Italian researchers have discovered that healthcare workers with… Read More »Pfizer vaccine may be less effective in people with obesity, says study
Healthcare regulator says it will update recommendations ‘very soon’ in wake of row over jab’s effectiveness in older candidates Coronavirus – latest updates See all our coronavirus coverage Germany could soon authorise the use of the AstraZeneca vaccine for seniors after the head of the… Read More »Germany signals AstraZeneca vaccine may be approved for over-65s
Vaccine, along with those from Pfizer and Moderna, should provide US with more than enough supply to vaccinate every person The battle against Covid-19 took a major step forward on Friday as the US moved closer to distributing its first one-shot Covid-19 vaccine, after an… Read More »Johnson & Johnson one-shot Covid vaccine gets nod from FDA advisory panel
While Enthusiasm Rises, a Persistent Minority Say They Definitely Will Not Get Vaccinated; Republicans, Rural Residents, and Essential Workers Outside Health Care Are Most Reluctant Groups More than half of Americans (55%) now say they want to get vaccinated as soon as possible (37%) or… Read More »Most Americans Now Say They’ve Gotten At Least One Dose of a COVID-19 Vaccine or Want to Get Vaccinated As Soon As Possible, with Enthusiasm Rising Across Racial, Ethnic and Partisan Groups
The Joint Committee on Vaccination and Immunisation (JCVI) has published advice on rolling out COVID-19 vaccination beyond the initial nine priority cohorts – with jabs to continue to be targeted by age.
Primary care network (PCN) COVID-19 vaccination sites have been paid £70m this month for the jabs they delivered in the first wave of the campaign in December and January, NHS England has revealed.
The Latest KFF COVID-19 Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. Black and Hispanic adults remain more likely to want to wait… Read More »KFF COVID-19 Vaccine Monitor: February 2021
Former prime minister tells the Guardian the world must be better prepared for the next pandemic World leaders could have cut the length of the Covid outbreak by three months if they had collaborated on vaccines, testing and drugs, Tony Blair has claimed as he… Read More »Blair says collaboration on Covid could have cut three months off crisis
Therapeutic Goods Administration may follow US in allowing vaccines to be stored at warmer temperatures Pfizer’s Covid-19 vaccine could soon be delivered at temperatures 50 degrees warmer than currently required if Australia follows the US’s lead to ease the rollout. The potential change in storage… Read More »Australia considers approving Pfizer Covid vaccine for standard cold storage
While Moderna is being hailed as a national saviour in the US, AZ’s only gain so far has been goodwill Compare and contrast. AstraZeneca is currently producing Covid vaccines for no profit and still manages to get beaten up by opportunists in Brussels. Over in… Read More »AstraZeneca and Moderna’s contrasting rewards for fighting Covid hardly seem fair
Better than expected revenues will push US firm founded in 2010 into profit for first time Coronavirus – latest updates See all our coronavirus coverage Moderna expects to rake in $18.4bn (£13bn) of sales from its coronavirus vaccine this year, marking a huge turnaround in… Read More »Moderna forecasts $18bn in sales of Covid vaccine this year
Almost half of people who experienced potential cancer symptoms in the first wave of the COVID-19 pandemic did not contact their GP, a study has shown.
CCGs with low uptake of COVID-19 vaccine in ethnic minority, marginalised or deprived communities will be supported to boost uptake through a £4.2m NHS fund.
Johnson & Johnson’s one-shot coronavirus vaccine is due to be reviewed by an FDA advisory committee on Friday, and according to the regulator meets the requirements for emergency use authorisation. In a briefing document published ahead of the Vaccines and Related Biological Products Advisory Committee… Read More »FDA reviewer backs J&J COVID jab for emergency OK
This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections.
This issue brief explores the impact of COVID-19 on justice-involved populations, examines how states have prioritized these populations for vaccination, and highlights the significance of Medicaid coverage for this population as well as proposals to expand access to Medicaid coverage.
Around 150,000 more people will be prioritised for COVID-19 vaccination after the Joint Committee on Vaccination and Immunisations (JCVI) backed jabs for all people on GP learning disability registers.
Updated versions of vaccine are being developed in case variants evade immunity provided by current shots Coronavirus – latest updates See all our coronavirus coverage Clinical trials of vaccines against new variants of coronavirus will start in the summer to ensure updated boosters are available… Read More »Vaccine clinical trials for Covid variants to start in summer, MPs told
London GP Dr Farzana Hussain is personally telephoning scores of patients who have yet to accept a COVID-19 jab in a bid to tackle low uptake in her area.
GP-led sites could deliver more than 100m doses of COVID-19 vaccine this year under government plans to offer first doses to the entire adult population by 31 July and start a booster jab campaign from autumn.
Expected shortfall of 90m doses could hit the EU’s ability to meet its target of vaccinating 70% of adults by summer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has told the European Union it expects to deliver less than half the Covid-19… Read More »AstraZeneca expected to miss EU Covid vaccine supply target by half in second-quarter – report
Factors at play include high uptake plus stockpiling for second doses, but Matt Hancock promises ‘bumper weeks in March’ Coronavirus – latest updates See all our coronavirus coverage The number of Covid vaccines administered in the UK has fallen by over a third in the… Read More »Number of UK Covid vaccinations falls by a third as vaccine supply dips
GP practices could be offered ‘additional discretionary payments’ to boost vaccine uptake in hard-to-reach patients, following an update to the COVID-19 enhanced service.
CCG-level data on COVID-19 vaccine coverage has been made available for the first time. GPonline breaks down what it shows and maps variation across England.
The government must not be afraid of ‘putting the brakes’ on its four-stage plan to ease lockdown in England if COVID-19 cases begin to rise again, the BMA has warned.
The spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks about its efficacy that now threaten to undermine the EU’s vaccination targets. The European Commission approved AZ’s AZD1222 vaccine for use in the EU in all adults… Read More »AZ COVID jab efficacy debate is hindering EU’s vaccine drive
As America’s biopharmaceutical researchers continue working around the clock to fight COVID-19, leaders in the health care ecosystem have come together to provide recommendations to strengthen America’s preparedness and future health care crises response.
A single dose of the Pfizer/BioNTech COVID-19 vaccine cuts risk of hospitalisation and infection substantially, Public Health England has confirmed, as prime minister Boris Johnson outlined a four-stage plan to ease lockdown.
As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop and manufacture safe and effective vaccines. To date, two vaccines have been granted Emergency Use Authorization (EUA) in the United States by the U.S. Food… Read More »Fighting variants of COVID-19
Preliminary data on the impact of COVID-19 vaccination in Scotland show that both the Pfizer/BioNTech and Oxford/Astra Zeneca jabs reduce risk of hospitalisation substantially – in results hailed as ‘very encouraging’.
An ‘active review’ is underway to investigate why healthy women with a previous diagnosis of gestational diabetes were wrongly advised to shield by the government’s QCovid risk tool, NHS Digital has confirmed.
The latest from the KFF COVID-19 Vaccine Monitor finds that Black men (45%) and women (41%) are more likely than other groups to want to “wait and see” how the COVID-19 vaccine works for others before getting it themselves, making them a key target for… Read More »KFF COVID-19 Vaccine Monitor: Attitudes Towards COVID-19 Vaccination Among Black Women and Men
Oxford Covid vaccine described in German media as ‘shelf warmer’ with only 17% of doses administered so far Coronavirus – latest updates See all our coronavirus coverage Politicians in Germany are stepping out in support of the AstraZeneca vaccine as public scepticism around the Oxford-developed… Read More »German politicians counter AstraZeneca vaccine scepticism with show of support
This analysis examines Black adults’ attitudes, concerns, and intentions regarding a COVID-19 vaccine. While Black men and women are similar in many of their views, there is a gender gap in some COVID-19 vaccine attitudes and intentions.
Novavax has signed a deal to provide 1.1 billion doses of its COVID-19 vaccine to the COVAX global initiative led by Gavi, the vaccine alliance, which aims to ensure fair access across the globe. There are growing concerns about the lack of COVID vaccines available… Read More »Novavax provides 1.1 billion COVID shots to global vaccine drive
Two researchers have suggested that the second dose of Pfizer and BioNTech’s COVID-19 vaccine could be delayed, as this would increase the number of people that can be protected while supplies are limited without compromising its efficacy. The two Canadian researchers – Danuta Skowronski and… Read More »Scientists make case for one dose of Pfizer’s COVID jab to stretch supplies
We have looked back at some of the biggest advances in 2020, but it’s a new year and time to look ahead, so we asked our Life Sciences team what they are looking forward to in 2021. “Predicting the unknown!” says Thibault Géoui, Senior Director… Read More »What Excites You Most About the Life Sciences Industry in 2021?
Pressure mounts for patent waivers to allow poorer countries to develop their own manufacturing capacity to boost availability The domination of global medicine by major pharmaceutical companies needs to be confronted to provide fairer access to vaccines, a leading South African official has said. The… Read More »South Africa leads backlash against big pharma over access to Covid vaccines
KFF has an updated analysis of state-reported data as of February 16, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity. New to the analysis are comparisons of vaccination rates in each racial/ethnic group based on state-reported data of total people who have received at… Read More »New Analysis: Updated State Data Continues To Show Wide Disparities in COVID-19 Vaccination Rates by Race/Ethnicity
KFF is collecting and analyzing data on COVID-19 vaccinations by race/ethnicity to gain increased insight who is receiving the vaccine and whether some groups are facing disparities in vaccination.
This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX’s organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.
When voters cast their ballots in the 2020 election, they made clear their focus on getting COVID-19 under control and fixing the economy. However, health care was still important to many voters, and in our review of public and PhRMA’s national and “state battleground” exit… Read More »Top five issues voters want addressed in the administration’s first 100 days
The House COVID-19 relief proposal would temporarily lower what millions of Marketplace enrollees and uninsured potential enrollees would pay toward premiums and would provide states that have not expanded their Medicaid programs a financial boost that would more than offset their costs initially, two new… Read More »Two New Analyses: House COVID-19 Relief Plan Would Temporarily Lower Marketplace Premiums for Millions and More than Offset Short-Term State Costs to Expand Their Medicaid Programs
This data note estimates how premiums would change for people at various ages and incomes under the subsidy schedule outlined in the House COVID-19 Relief Proposal.
The BMA has backed calls from MPs for NHS workers with long COVID to receive financial compensation, amid criticism that staff suffering from the condition have been abandoned by the government.
GlaxoSmithKline is expanding a coronavirus antibody collaboration with US biotech Vir, to include potential therapies for flu and other respiratory viruses. The big UK pharma is already working with Vir on antibody therapies for coronaviruses, and already have the antibody VIR-7831 in clinical trials including… Read More »GSK expands coronavirus antibody tie-up to include potential flu therapies
Sometime within the next few weeks, young and healthy volunteers will be deliberately exposed to the COVID-19 coronavirus in the UK in what looks set to be the first study of its type worldwide. The human challenge study has just secured ethics committee approval and… Read More »UK will start first COVID-19 challenge study “within a month”
More than 1,000 GPs returned to the performers list to support the COVID-19 vaccination campaign, NHS England has revealed – as it confirmed a £10 supplement for vaccinating people in residential settings.
GP practices face a surge in administrative workload after the addition of 1.7m patients to shielding lists in England – but the overhaul has been broadly welcomed.
More than 800,000 extra patients will be prioritised for COVID-19 vaccination after a major expansion of the shielding list based on data from a risk assessment tool.
More than 800,000 extra patients have been added to the shielding list and will be prioritised for COVID-19 jabs based on data from a risk assessment tool.
General practice teams have been praised by the BMA for their ‘amazing effort’ in helping to deliver 15m first doses of COVID-19 vaccine in the midst of the pandemic.
General practice teams have been praised by the BMA for their ‘amazing effort’ in helping to deliver 15m first doses of COVID-19 vaccine in the midst of the pandemic.
GP-led vaccination sites have delivered nearly 10m doses of COVID-19 vaccine in the past month alone as the UK met its target of offering a first dose to 15m people by 15 February.
GP-led vaccination sites have delivered nearly 10m doses of COVID-19 vaccine in the past month alone as the UK met its target of offering a first dose to 15m people by 15 February.
A year ago, two scientists began work on the response to a new virus. Now, as their vaccine is being given to millions, they tell of their incredible 12 months Exactly a year ago, Oxford University scientists launched a joint enterprise that is set to… Read More »Life savers: the amazing story of the Oxford/AstraZeneca Covid vaccine
A huge effort has helped the UK provide 14m first doses of Covid vaccines in about two months Coronavirus – latest updates See all our coronavirus coverage In St Albans, GPs took over a former nightclub to provide Covid vaccinations every 20 seconds; in Carnforth,… Read More »‘It shows what we’re capable of’: the NHS’s vaccine triumph
Strong and reliable IP protections – including patents – have supported America’s robust innovation ecosystem by promoting discovery, development, affordability and access to new treatments and cures. As our industry continues to expand vaccine production and deliver medicines to patients in need, reliable IP protections… Read More »The latest: What they are saying: Intellectual property protections vital to COVID-19 research, development and manufacturing
This brief examines how people to “wait and see” how the COVID-19 vaccine is working for other people before getting vaccinated themselves with different partisan identities and those belonging to different racial and ethnic groups differ in their levels of concern about the vaccine and… Read More »KFF COVID-19 Vaccine Monitor: What Do We Know About Those Who Want to “Wait and See” Before Getting a COVID-19 Vaccine?
GPs will start vaccinating patients in ‘cohort 6’ – those aged 16-64 with underlying health conditions – from 15 February, and will focus on administering second doses for other patients from 1 March.
President Biden’s January 28th executive order to reopen enrollment in the federal ACA Marketplace from February 15 through May 15, combined with $50 million in federal spending on outreach and education about ACA coverage options, has the potential to reach millions of people who were… Read More »ACA Open Enrollment Matters for Medicaid Coverage, Too
Nearly nine in 10 people aged over 70 in England have received a first dose of COVID-19 vaccine as the NHS nears its target of administering 15m first doses UK-wide by 15 February.
Nearly nine in 10 people aged over 70 in England have received a first dose of COVID-19 vaccine as the NHS nears its target of administering 15m first doses UK-wide by 15 February.
The generic respiratory drug budesonide could be an option to treat COVID-19, a small scale clinical study has suggested. Marketed in the past by AstraZeneca as Pulmicort, budesonide is an off-patent inhaled steroid and could be used to prevent the risk of people getting seriously… Read More »Generic inhaled steroid could treat early COVID-19, study finds
BMA leaders have hit out at plans for ‘sweeping reorganisation’ of the NHS set out by the government as the health service struggles with the COVID-19 pandemic.
Anglo-Swedish pharmaceutical firm’s profits rise to $7.4bn as main business ‘remains strong’ Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has said it could take between six and nine months to produce Covid-19 vaccines that are effective against new variants of the coronavirus.… Read More »AstraZeneca says vaccine against new Covid variants may take six months
The COVID-19 pandemic has affected nearly every aspect of society, including the way scientists conduct the testing of medicines.
MPs have given the government until July to report on whether PPE shortages directly contributed to COVID-19 infections and deaths in NHS staff, after a report warned health professionals had ‘risked their own and families lives’ to provide care.
MPs have given the government until to July to report on whether PPE shortages directly contributed to COVID-19 infections and deaths in NHS staff, after a report warned health professionals had ‘risked their own and families lives’ to provide care.
A mounting toll of COVID-19 infection among staff involved in waste collection from NHS vaccination sites threatens to slow down the vaccine rollout, a waste collection management company has warned.
A mounting toll of COVID-19 infection among staff involved in waste collection from NHS vaccination sites threatens to bring the vaccine rollout to a halt, a waste collection company has warned.
Sir Elton John and Sir Michael Caine have recorded a video backing COVID-19 jabs, ending with the actor delivering a message in trademark style: ‘My name is Michael Caine. I’ve just had a vaccine for COVID. It didn’t hurt – not a lot of people… Read More »Michael Caine and Elton John record video to promote COVID-19 vaccine
Practices have faced an ‘avalanche’ of calls from patients after the opening of mass vaccination sites left many confused over where to go for COVID-19 jabs – putting patient care at risk, GPs have warned.
Practices have faced an ‘avalanche’ of calls from patients after the opening of mass vaccination sites left many confused over where to go for COVID-19 jabs – putting patient care at risk, GPs have warned.
From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators Coronavirus – latest updates See all our coronavirus coverage The Oxford University/AstraZeneca vaccine against Covid has barely been out of the news from… Read More »A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence
This issue brief provides an overview of the Biden administration’s COVID-19 and global health actions to date, as well as likely ones on the horizon, and identifies key policy issues and outstanding questions ahead.
The UK government’s massive spending on the coronavirus pandemic response has been “rife with conflicts of interest”, says the opposition Labour Party, and an independent watchdog should be set up to oversee procurement contracts. That was the message delivered by shadow Cabinet Office minister Rachel… Read More »Labour accuses government of cronyism in COVID-19 contracts
This report summarizes the public’s response to a series of open-ended questions aimed at better understanding people’s concerns around receiving a COVID-19 vaccine and the views of the messages and messengers that could affect their willingness to get one,
The government has urged people over 70 who have yet to receive a first dose of COVID-19 vaccine to book a jab as the UK targets 15m first doses by 15 February.
GPs face intense pressure as the profession targets COVID-19 jabs for over 50s by May, with a booster campaign to follow – amid concerns that patients requiring proof of vaccination for holidays will land practices with extra red tape.
A national publicity campaign backed by faith leaders and public figures from black, Asian and minority ethnic (BAME) communities is needed to increase uptake of the COVID-19 vaccine in groups hit hard by the virus, the RCGP has warned.
Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have… Read More »Oxford Covid vaccine 10% effective against South African variant, study suggests
The UK has agreed a 50 million-dose order for a COVID-19 vaccine with German biotech CureVac to support development of a shot that specifically targets emerging variants of the virus. The agreement will see the UK work with CureVac develop “new varieties of vaccines based… Read More »UK targets COVID-19 variants with new order for CureVac jab
As we settle into a new year, it’s always good to take a moment to consider what was accomplished in the previous one. That’s why we asked members of Elsevier’s Life Sciences team what they felt were among the most noteworthy advances in the life… Read More »What Were the Biggest Advances in Life Sciences in 2020?
GP-led vaccination sites in England are to receive an additional £10 for administering the COVID-19 vaccine to housebound patients.
The Anglo-Swedish firm already had a strong lineup of cancer drugs when vaccine success gave it a further boost Before the pandemic, AstraZeneca was highly regarded in the business and pharmaceutical world – seen as one of the UK’s best companies. Now, thanks to Britain’s… Read More »AstraZeneca set to weather Covid in better health than rivals
GPs with long COVID have lost their jobs because a lack of financial support has left practices facing the ‘impossible choice’ of reducing services or letting staff go, the BMA has warned.